Open AccessVitamin D deficiency and cardiometabolic syndrome: Is the evidence solid?
Author(s) -
Lubna Mahmood,
Reem Al Saadi,
Lorraine E Matthews
Publication year - 2017
Publication title -
archives of medicine and health sciences
Language(s) - English
Resource type - Journals
eISSN - 2321-6085
pISSN - 2321-4848
DOI - 10.4103/amhs.amhs_80_17
Subject(s) - medicine , dyslipidemia , metabolic syndrome , vitamin d and neurology , vitamin d deficiency , diabetes mellitus , obesity , disease , type 2 diabetes , endocrinology , vitamin , population , physiology , environmental health
Vitamin D is a fat-soluble vitamin which has an important role in bone metabolism with some anti-inflammatory and immune-modulating properties. It is very unique since it can be made in the skin from exposure to sunlight. Cardiometabolic syndrome (CMS) is a group of metabolic abnormalities that can increase the risk of cardiovascular disease and type 2 diabetes. It develops in an individual with any three of the following risk factors including obesity, diabetes, hypertension, dyslipidemia, and thrombosis. Both dietary and environmental factors, when combined with a sedentary lifestyle, lead to metabolic syndrome (MS) risk factors. The research outcomes propose to increase the current Vitamin D fortification level in foods to reduce the risk factors of the MS. Further researches are needed before clinical practice can recommend a Vitamin D prescription as a treatment for CMS in the general population